Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$9.5M
+168.2% from 2023
Prescriptions
35K
$272.26 per claim
Patients
18K
13,920 prescribers
Total spending, 2024
$9.5M
$519.00 per patient
Medicare prescription drug plans paid $9.5M for Insulin Degludec Pen (U-200) in 2024, for 34,815 prescriptions and refills to 18,263 patients (up 168.2% from 2023). The average cost per claim was $272.26.
Texas had the highest Medicare cost for Insulin Degludec Pen (U-200) in 2024: $1.2M for 4,119 claims, followed by Florida ($857K).
Janet Martinez, nurse practitioner in Miami, FL, had the highest Medicare cost for Insulin Degludec Pen (U-200) in 2024: 1,643 claims costing $209K.
Insulin Degludec Pen (U-200) is made by Novo Nordisk A/S (NVO), listed in the Medicare spending data as Novo Nordisk.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Janet Martinez Miami, FL | Nurse Practitioner | 1,643 | 288 | $209K |
| Daile Grave de Peralta Miami, FL | Internal Medicine | 316 | 67 | $63K |
| Valentina Salvat Garcia |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 332 | 479 | 344 | $137K |
| 2023 | 5,650 | 12,233 | 6,506 | $3.5M |
| 2024 | 13,920 | 34,815 | 18,263 | $9.5M |
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Nurse Practitioner |
| 392 |
| 65 |
| $57K |
| Gerald Miceli Ormond Beach, FL | Endocrinology | 117 | 29 | $26K |
| Daniela M Dicenso Miami, FL | Internal Medicine | 128 | 22 | $24K |
| Deepak K Kashyap Falls Church, VA | Endocrinology | 21 | Under 11 | $22K |
| Chadi Richeh Rancho Mirage, CA | Endocrinology | 29 | 16 | $20K |
| Silvia M Cuadra Mongalo Port Orange, FL | Endocrinology | 83 | 19 | $19K |
| Michelle A Chico Shreveport, LA | Endocrinology | 31 | 12 | $14K |
| Emily E Peterson La Crosse, WI | Physician Assistant | 18 | Under 11 | $13K |
| Jaweed Akhter Beaumont, TX | Endocrinology | 39 | 21 | $13K |
| Hesham M Bazaraa Munster, IN | Endocrinology | 11 | Under 11 | $13K |
| Matthew Loudon Wasilla, AK | Physician Assistant | 12 | Under 11 | $13K |
| Tonya I Koopman Bend, OR | Nurse Practitioner | 48 | 19 | $13K |
| Anna Marie Soriano-Samson Lake Elsinore, CA | Nurse Practitioner | 14 | Under 11 | $12K |
| Rachel L McKenney La Crosse, WI | Endocrinology | 18 | Under 11 | $12K |
| Ashley Williams Plattsburgh, NY | Physician Assistant | 17 | Under 11 | $11K |
| Ashley A Aaron Waco, TX | Nurse Practitioner | 23 | 14 | $9,650 |
| Pamela Lopez Weslaco, TX | Nurse Practitioner | 37 | 29 | $9,201 |
| Rachel Fields Eugene, OR | Nurse Practitioner | 26 | Under 11 | $9,000 |
| Mario L Vasquez Aguilar Rio Grande City, TX | Family Practice | 31 | 22 | $8,953 |
| Ashley N Briggs Palm Coast, FL | Nurse Practitioner | 49 | Under 11 | $8,884 |
| Antonio Marrero Miami, FL | Nurse Practitioner | 56 | 14 | $8,860 |
| Kathryn E Sander Spokane, WA | Nurse Practitioner | 11 | Under 11 | $8,582 |
| Richard Millstein Greeley, CO | Endocrinology | 11 | Under 11 | $8,582 |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Novo Nordisk NVO | 34,823 | $9.5M |